新しい 協力 者 たち は,かつて 宣伝 さ れ て い た がん 治療 方法 に 活力 を 与え て いる
PubMedで要約を見る
まとめ
この要約は機械生成です。血管新生阻害剤は かつては失敗でしたが 今や 免疫チェックポイント薬と併用することで 癌の治療に新たな可能性を秘めています この組み合わせ治療は 患者の治療結果を改善する 新しい希望の道を示しています
科学分野
- 腫瘍学
- 免疫学
- 血管生物学
背景
- 血管新生阻害剤は腫瘍の血管形成を阻害することを目的としています.
- 血管新生阻害剤を単独で投与した以前の試験では,有効性が限られていた.
- 免疫チェックポイント阻害剤 (ICI) は 免疫系を活性化することで 癌治療に革命をもたらしました
研究 の 目的
- 血管新生阻害剤と免疫チェックポイント薬の組み合わせのシナジスティックの可能性を評価する.
- 現在のがん治療に対する耐性を克服するための新しい治療戦略を探求する.
主な方法
- 組み合わせ治療の有効性を評価する臨床前モデル.
- 血管新生阻害剤とICIの併用による安全性と反応率を評価する臨床試験
- 治療への反応を予測する要因を特定するためのバイオマーカー分析
主要な成果
- 併用治療は,臨床前試験において,単独治療と比較して,抗腫瘍活性が強化されたことを示した.
- 早期の臨床データは,特定のがんの治療応答率の改善と持続的な寛解を示唆している.
- 治療の成功に関連した特定の免疫および血管新生シグネチャーの特定
結論
- 血管新生阻害剤と免疫チェックポイント薬の組み合わせは 有望な治療戦略です
- このアプローチは単剤治療の限界を克服し,がん患者の治療選択肢を広げることができます.
- 患者の選択と治療法を最適化するために,さらなる調査が必要である.
関連する概念動画
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

